Nighthawk Biosciences Inc (NHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,015 | -23,380 | -19,195 | -48,144 | -48,800 |
| Depreciation Amortization | 44,924 | 40,518 | 32,393 | 83,546 | 80,119 |
| Income taxes - deferred | -1,322 | -110 | -9,790 | -13,804 | -14,497 |
| Accounts receivable | 3,839 | 2,346 | 340 | 2,545 | -286 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -454 | N/A |
| Other Working Capital | -4,975 | -7,545 | -1,383 | 2,135 | -188 |
| Other Operating Activity | -1,175 | -1,078 | 392 | 2,553 | 5,184 |
| Operating Cash Flow | $16,276 | $10,751 | $2,757 | $28,377 | $21,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,000 | 6,000 | 6,000 | -5,988 | -5,989 |
| PPE Investments | -2,478 | -1,769 | -929 | -6,699 | -4,414 |
| Net Acquisitions | 2,000 | 2,000 | N/A | N/A | N/A |
| Other Investing Activity | 7,910 | 7,500 | 0 | 0 | 0 |
| Investing Cash Flow | $13,432 | $13,731 | $5,071 | $-12,687 | $-10,403 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26,531 | -26,401 | -201 | -15,894 | -12,686 |
| Common Stock Issued | 98 | 55 | 7 | 134 | 91 |
| Common Stock Repurchased | N/A | N/A | N/A | -20,342 | -20,342 |
| Other Financing Activity | -4,694 | -118 | 2 | -455 | -441 |
| Financing Cash Flow | $-31,127 | $-26,464 | $-192 | $-36,557 | $-33,378 |
| Beginning Cash Position | 26,293 | 26,293 | 26,293 | 47,160 | 47,160 |
| End Cash Position | 24,874 | 24,311 | 33,929 | 26,293 | 24,911 |
| Net Cash Flow | $-1,419 | $-1,982 | $7,636 | $-20,867 | $-22,249 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,276 | 10,751 | 2,757 | 28,377 | 21,532 |
| Capital Expenditure | -2,478 | -1,769 | -929 | -6,699 | -4,414 |
| Free Cash Flow | 13,798 | 8,982 | 1,828 | 21,678 | 17,118 |